257 related articles for article (PubMed ID: 11898580)
21. Secondary prevention of stroke: a practical guide to drug treatment.
Koennecke HC
CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903
[TBL] [Abstract][Full Text] [Related]
22. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
23. Medical therapy for secondary prevention of stroke.
Regesta G
Clin Exp Hypertens; 2002; 24(7-8):555-62. PubMed ID: 12450231
[TBL] [Abstract][Full Text] [Related]
24. [Antithrombotic therapy in the secondary prevention of stroke].
Mel'nikova EV; Kadinskaia MI; Gerasimenko DV; Shmonin AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):23-7. PubMed ID: 21626814
[TBL] [Abstract][Full Text] [Related]
25. Antiplatelet aggregating versus anticoagulant agents in preventing early recurrent stroke among patients with atrial fibrillation.
Adams HP
Curr Neurol Neurosci Rep; 2001 Jan; 1(1):11-2. PubMed ID: 11898494
[No Abstract] [Full Text] [Related]
26. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
[TBL] [Abstract][Full Text] [Related]
27. Use of anticoagulants or antiplatelet aggregating drugs in the prevention of ischemic stroke.
Adams HP
Adv Intern Med; 1995; 40():503-31. PubMed ID: 7747656
[No Abstract] [Full Text] [Related]
28. Transient ischaemic attacks : new approaches to management.
Madhavan R; Chaturvedi S
CNS Drugs; 2003; 17(5):293-305. PubMed ID: 12665389
[TBL] [Abstract][Full Text] [Related]
29. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
Johnson P; Rosewell M; James MA
Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic treatment in the prevention of ischemic stroke.
Emre U; Rantanen K; Tatlisumak T
Curr Drug Targets; 2007 Jul; 8(7):817-23. PubMed ID: 17630934
[TBL] [Abstract][Full Text] [Related]
31. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
32. P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.
Liu F; Tantry US; Gurbel PA
Expert Opin Pharmacother; 2015 Jun; 16(8):1149-65. PubMed ID: 25873127
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
[TBL] [Abstract][Full Text] [Related]
34. [Secondary prophylaxis of stroke from a neurological perspective].
Seidel G
Herz; 2013 May; 38(3):251-60. PubMed ID: 23471343
[TBL] [Abstract][Full Text] [Related]
35. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Simmons BB; Yeo A; Fung K; ;
Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
[TBL] [Abstract][Full Text] [Related]
36. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Lalouschek W; Lang W; Müllner M;
Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
[TBL] [Abstract][Full Text] [Related]
39. Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.
Shrestha S; Coy S; Bekelis K
Curr Pharm Des; 2017; 23(9):1377-1391. PubMed ID: 28003013
[TBL] [Abstract][Full Text] [Related]
40. Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke.
Kim D; Lee SH; Joon Kim B; Jung KH; Yu KH; Lee BC; Roh JK;
Eur Heart J; 2013 Sep; 34(35):2760-7. PubMed ID: 23729692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]